News
Johns Hopkins finds positive result in COVID-19 ARDS treated patients with Cellenkos' Cord Blood cells
Physician-investigators at the Johns Hopkins University Hospital found promising data of treatment of COVID-19 induced ARDS with allogeneic, cord blood derived T-regulatory (Treg) cell therapy
Pfizer, BioNTech announce early positive data from an ongoing phase 1/2 study of SARS-COV-2 vaccine
Pfizer and BioNTech SE have announced preliminary data from the most advanced of four investigational vaccine candidates from their BNT162 mRNA-based vaccine program.
